U.S. Hospitality Stock News

In late February 2026, Butterfly Network, Inc. reported Q4 2025 results showing US$31.51 million in revenue versus US$22.35 million a year earlier, narrower quarterly losses, and issued 2026 revenue guidance of US$117 million to US$121 million alongside a new US$57.00 million shelf registration for ESOP-related Class A shares. The company’s first quarter of positive operating cash flow, boosted by its Midjourney partnership and Compass AI launch, highlights a shift toward higher-margin,...

Why Halozyme Therapeutics Is On Investors’ Radar Today Halozyme Therapeutics (HALO) is drawing attention as investors weigh its recent share performance, including a modest 1 day gain and mixed short term returns, in relation to its current valuation and underlying biopharmaceutical licensing business. See our latest analysis for Halozyme Therapeutics. At the current share price of US$69.53, Halozyme Therapeutics has seen short term share price pressure with a 7 day return of 2.04% and 30 day...

Invitation Homes (INVH) has come into focus after issuing 2026 guidance for same store core revenue growth of 1.3% to 2.5%, together with detailed fourth quarter and full year 2025 results. See our latest analysis for Invitation Homes. At a share price of US$26.34, Invitation Homes has seen a 4.11% 7 day share price return but a weaker 1 year total shareholder return of 19.53% decline, suggesting recent momentum is improving after a softer stretch. If this single name feels interest rate...

If you are trying to work out whether Roku at around US$98.41 is priced for opportunity or disappointment, starting with a clear view of its current valuation is essential. The stock has had a mixed run, with a 10.5% return over the last 7 days and 3.4% over the last 30 days, set against a 9.5% year to date decline and longer term returns of 17.8% over 1 year, 50.0% over 3 years, and a 72.2% decline over 5 years. Recent headlines have continued to focus on Roku's position in streaming...

Associated Banc-Corp (ASB) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months, while longer term performance remains positive. See our latest analysis for Associated Banc-Corp. Recent trading has cooled, with a 1-day share price decline of 5.95% and a 7-day share price decline of 7.53%. However, the 1-year total shareholder return of 10.28% and 5-year total shareholder return of 48.16% indicate that...

Simply Good Foods recently brought founder Joe Scalzo back as CEO on January 19, 2026, alongside a 2 million stock option grant and a US$199,000 share purchase by the CFO, signaling renewed leadership commitment. This leadership return and insider buying sparked a sharp rise in retail investor interest on Reddit, highlighting how management alignment can influence market sentiment for a consumer nutrition company positioned at the intersection of fitness, wellness, and everyday eating. With...

Wondering whether Robinhood Markets at around US$75.85 still offers fair value or has run ahead of itself? This article walks through what the numbers are really saying about the stock. The share price is roughly flat over the last week with a 0.3% decline, after a sharper 25.1% decline over 30 days that comes on the back of a 51.4% return over the past year and a very large gain of about 7x over three years. Recent headlines have focused on Robinhood's role in retail trading, its zero...

Progyny’s recent share moves in focus Progyny (PGNY) has been under pressure, with the stock showing negative returns over the past month, past 3 months and year. This has prompted investors to reassess how its current valuation lines up with its underlying business. See our latest analysis for Progyny. The sharp 1 day share price decline of 20.49% to US$17.69 adds to already weak momentum, with the 1 year total shareholder return of 21.48% and 3 year total shareholder return of 51.15% both...

If you are trying to figure out whether Freshpet at around US$84.45 is a bargain or already pricing in a lot of optimism, you are asking the right question for this stock. The share price performance has been mixed, with a 13.3% return over the last 7 days, 21.2% over 30 days, 40.4% year to date, but a 21.1% decline over 1 year and a 39.4% decline over 5 years. These swings mean recent news and expectations have become a big part of the story, as investors reassess what they are willing to...

Upcoming earnings put Astrana Health in focus Astrana Health (ASTH) is back on investors’ radar ahead of its March 2, 2026 quarterly earnings report, with attention on whether results and guidance align with the company’s recent revenue and earnings profile. See our latest analysis for Astrana Health. At a share price of US$20.33, Astrana Health has seen recent momentum soften, with a 30 day share price return of 10.6% decline and a 1 year total shareholder return of 19.9% loss, even as its...

CIBC and BMO Capital have both highlighted Brookfield Business Partners (NYSE:BBU) with fresh Outperform ratings, drawing attention to its track record, ties to the broader Brookfield group, and current valuation. See our latest analysis for Brookfield Business Partners. At around US$34.08, Brookfield Business Partners has seen short term share price pressure, with a 1-day share price return of 1.70% decline and a year to date share price return of 4.88% decline. However, its 1-year total...

United Rentals (NYSE:URI) and Procore Technologies launched a new telematics integration that brings rental equipment data directly into Procore's Resource Management solution. The collaboration connects jobsite equipment usage and location data with project planning tools to support more precise resource allocation. The integration is designed to help contractors address equipment inefficiencies and improve coordination across construction projects. For you as an investor, this move sits...

In February 2026, CRH plc reported fourth‑quarter 2025 revenue of US$9,416 million and net income of US$1,025 million, delivering record full‑year 2025 results with revenue of US$37,447 million and net income of US$3,753 million, alongside a 5% increase in its quarterly dividend to US$0.39 per share and continued share buybacks. CRH also issued 2026 guidance for net income of US$3.90–US$4.10 billion and diluted EPS of US$5.60–US$6.05, which, together with sustained margin expansion, higher...

Deere (DE) is back in focus after raising its full-year 2026 earnings guidance, reporting first quarter results, and expanding its precision agriculture connectivity through a new Bayer partnership. See our latest analysis for Deere. The raised guidance, stronger first quarter sales and the new Bayer connectivity feature have arrived alongside a 34.9% year to date share price return and a 92.14% five year total shareholder return. This suggests momentum has recently strengthened after a...

Cipher Digital, formerly focused on Bitcoin mining, has completed a full pivot to high performance computing infrastructure under the ticker NasdaqGS:CIFR. The company has rebranded, exited its legacy mining stakes, and repositioned itself as an operator of HPC data centers. Cipher Digital has secured long term data center agreements with major cloud providers including AWS, Fluidstack, and Google. The company has raised capital through bond offerings to support its shift toward hyperscale...

Sharplink, Inc. recently appointed veteran cryptocurrency journalist Steven Ehrlich as Head of Research and Communications to strengthen its outreach to retail and institutional investors around the long term Ethereum opportunity. This hire brings a high-profile crypto media voice in-house, potentially sharpening how Sharplink explains and positions its large Ethereum treasury platform to the market. With Ehrlich’s communications experience now in place, we’ll explore how this leadership...

Cytokinetics (CYTK) has been drawing investor attention after a period of mixed share performance, with a roughly 1.5% decline over the past month and about a 5.8% decline over the past 3 months. See our latest analysis for Cytokinetics. At a share price of US$62.22, Cytokinetics has given up some near term momentum with a 7 day share price return of negative 8.42%. However, its 1 year total shareholder return of 35.26% and 5 year total shareholder return of 216.16% show that longer term...

Universal Health Services, Inc. recently reported its fourth-quarter and full-year 2025 results, with quarterly net revenues of US$4,486.05 million and net income of US$445.94 million, alongside full-year net revenues of US$17,364.83 million and net income of US$1,488.8 million. At the same time, management issued 2026 guidance calling for net revenues of about US$18.42–US$18.79 billion and diluted EPS of US$22.64–US$24.52, highlighting expectations for continued growth despite recent...

JetBlue Airways (JBLU) drew fresh investor attention after reporting a wider-than-expected fourth quarter loss and issuing guidance that highlights expected capacity growth, cost trends excluding fuel, and potential revenue per seat improvements. See our latest analysis for JetBlue Airways. JetBlue's latest quarter and guidance arrive after a choppy year, with a 90 day share price return of 23.94% and a 1 year total shareholder return of 15.03% decline. This suggests that short term momentum...

In February 2026, Genuine Parts Company reported fourth-quarter and full-year 2025 results showing higher sales but a net loss in the quarter, issued 2026 guidance, raised its annual dividend to US$4.25 per share, outlined continued M&A spending of US$300 million to US$350 million, and advanced plans to separate its automotive and industrial businesses by early 2027. An interesting angle is that Genuine Parts is pairing a 70th consecutive year of dividend increases with a planned business...

If you are wondering whether EZCORP is attractively priced after its recent run, this article will walk through how the current share price stacks up against several valuation checks. EZCORP last closed at US$26.53, with returns of 4.6% over the past 7 days, 23.7% over 30 days, 32.3% year to date and 92.8% over 1 year. The 3 year and 5 year returns sit at 192.8% and 410.2% respectively. Recent news coverage around EZCORP has focused on its role in the diversified financials space and...

If you are wondering whether Napco Security Technologies' current share price reflects its true worth, you are not alone. Many investors are trying to work out if the recent run still leaves room for value. The stock closed at US$46.61, with returns of 1.6% over the last 7 days, 26.3% over 30 days, 12.6% year to date and 92.9% over 1 year. The 3 year and 5 year returns stand at 47.4% and 182.8% respectively. Recent news coverage has largely focused on Napco Security Technologies as a...

American Superconductor (AMSC) is back in focus after reporting fiscal third quarter earnings per share of $2.81 on revenue that was 20% higher than a year earlier, far above prior expectations. See our latest analysis for American Superconductor. Despite the earnings surprise, American Superconductor’s share price has recently cooled, with a 1-day share price return of a 6% decline and a 7-day share price return of a 4% decline, following a 30-day share price return of 8.9% and a 1-year...

In late February 2026, Assurant reported its fourth quarter and full-year 2025 results, marking a ninth consecutive year of profitable growth and announcing a US$250 million to US$350 million share repurchase range for 2026. Positive coverage from major firms, including reiterated Hold and Buy ratings, underscored how earnings resilience and capital return plans are shaping investor perceptions of Assurant’s business quality. Next, we’ll examine how Assurant’s sustained profitable growth and...